Key facts
- It has raised $550K; the latest was Seed Round ($250K) in Aug 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for EndoAxis
- ·The full record, as it builds
Funding rounds
No funding rounds for EndoAxis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EndoAxis
Developer of a lab testing and healthcare platform designed to simplify lab testing translation and provide personalized supplements. The company's platform allows users to answer questions and get a background check on them, based on the patterns captured from each lab result, and provides personalized supplements to help them enhance their lifestyles.
- Sector
- Healthcare
- HQ
- Beverly Hills, CA, United States
- Founded
- 2020
- Employees
- 5
- Website
- endoaxis.com/
- Ownership
- Privately Held (backing)
EndoAxis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EndoAxis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EndoAxis in its N-PORT filings yet. We sweep new filings monthly.